254 related articles for article (PubMed ID: 30719143)
1. The Prognostic Value of Pretreatment Plasma Fibrinogen in Urological Cancers: A Systematic Review and Meta-analysis.
Song H; Kuang G; Zhang Z; Ma B; Jin J; Zhang Q
J Cancer; 2019; 10(2):479-487. PubMed ID: 30719143
[No Abstract] [Full Text] [Related]
2. Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis.
Su S; Liu L; Li C; Zhang J; Li S
Front Oncol; 2020; 10():1650. PubMed ID: 33014827
[No Abstract] [Full Text] [Related]
3. Prognostic significance of pretreatment controlling nutritional status score in urological cancers: a systematic review and meta-analysis.
Niu X; Zhu Z; Bao J
Cancer Cell Int; 2021 Feb; 21(1):126. PubMed ID: 33608012
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: A systematic review and meta-analysis.
Su S; Liu L; Li C; Zhang J; Li S
Int J Surg; 2019 Dec; 72():146-153. PubMed ID: 31707011
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
Qi F; Xu Y; Zheng Y; Li X; Gao Y
Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis.
Perisanidis C; Psyrri A; Cohen EE; Engelmann J; Heinze G; Perisanidis B; Stift A; Filipits M; Kornek G; Nkenke E
Cancer Treat Rev; 2015 Dec; 41(10):960-70. PubMed ID: 26604093
[TBL] [Abstract][Full Text] [Related]
7. Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis.
Wang Z; Wang X; Wang WD; Zheng GY; Guo H; Zhang YS
Chin Med Sci J; 2020 Sep; 35(3):262-271. PubMed ID: 32972504
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of Serum Lactate Dehydrogenase in Patients With Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Wu M; Lin P; Xu L; Yu Z; Chen Q; Gu H; Liu C
Front Oncol; 2020; 10():677. PubMed ID: 32509573
[No Abstract] [Full Text] [Related]
9. Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis.
Zhou L; Cai X; Liu Q; Jian ZY; Li H; Wang KJ
Sci Rep; 2015 Aug; 5():12733. PubMed ID: 26235332
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin to globulin ratio prior to treatment as a potential non-invasive prognostic indicator for urological cancers.
Xia Z; Fu X; Yuan X; Li J; Wang H; Sun J; Wu J; Tang L
Front Nutr; 2022; 9():1012181. PubMed ID: 36386921
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Plasma Fibrinogen in Lung Cancer Patients: A Meta-Analysis.
Zhong H; Qian Y; Fang S; Wang Y; Tang Y; Gu W
J Cancer; 2018; 9(21):3904-3911. PubMed ID: 30410594
[No Abstract] [Full Text] [Related]
12. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis.
Kim SI; Kim SJ; Kim SJ; Cho DS
Urol Oncol; 2021 Oct; 39(10):623-630. PubMed ID: 34253447
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative albumin-to-alkaline phosphatase ratio in patients with surgically treated urological cancer: a systematic review and meta-analysis.
Ren S; Wang H; Yang B; Zheng Y; Ou Y; Bao Y; Mao Y; Feng Y
Front Oncol; 2023; 13():1236167. PubMed ID: 38023164
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis.
Li DY; Hao XY; Ma TM; Dai HX; Song YS
Sci Rep; 2017 Nov; 7(1):15387. PubMed ID: 29133845
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer.
Zhang Y; Cao J; Deng Y; Huang Y; Li R; Lin G; Dong M; Huang Z
Clinics (Sao Paulo); 2020; 75():e993. PubMed ID: 32130355
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of Pretreatment Plasma D-Dimer in Patients with Solid Tumors: a Systematic Review and Meta-Analysis.
Li W; Tang Y; Song Y; Chen SH; Sisliyan N; Ni M; Zhang H; Zeng Q; Hou B; Xie X; Chang D
Cell Physiol Biochem; 2018; 45(4):1663-1676. PubMed ID: 29490291
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of radiologically determined sarcopenia prior to treatment in urologic tumors: A meta-analysis.
Li J; Deng Y; Zhang M; Cheng Y; Zhao X; Ji Z
Medicine (Baltimore); 2019 Sep; 98(38):e17213. PubMed ID: 31567976
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis.
Wang Q; Zhu SR; Huang XP; Liu XQ; Liu JB; Tian G
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1302-1310. PubMed ID: 33629300
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pretreatment plasma fibrinogen in patients with colorectal cancer: A systematic review and meta-analysis.
Li M; Wu Y; Zhang J; Huang L; Wu X; Yuan Y
Medicine (Baltimore); 2019 Sep; 98(37):e16974. PubMed ID: 31517816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
